Full Press Release Details
Acquisition Corp. Announces
Deadline to Complete Initial Business Combination
Raton, FL, August 1, 2023 - Digital Health Acquisition Corp. (the "Company" or "Digital Health")
(NASDAQ: DHAC), announces that on July 31, 2023 the Company extended the date by which the Company must consummate an initial
business combination (the "Deadline Date") for an additional three months from August 8, 2023 to November 8,
2023. The extension is the third of three additional three-month extensions permitted under the
Company's governing documents and provides the Company with additional time to complete its initial business
Health Acquisition Corp.
About VSee Labs, Inc
Telehealth Solutions, Inc.
Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase,
reorganization or similar business combination with one or more businesses.
is no-code or low-code SAAS platform that enables clinicians and enterprises to create their telehealth workflows without programming.
VSee's system encapsulates more than 500 man-years of development to allow a telehealth mobile app to be created or a telehealth
system to be integrated into existing hospital operations in days.
iDoc Virtual Telehealth
Solutions, Inc. is an acute care organization, set of integrated telehealth technologies, and team of neurointensivists, neurologists,
and nurses that treat and coordinate care for acutely ill patients 24/7 in the Neurointensive Care Unit (NICU) and ICU for stroke, brain
trauma, and a wide range of neurological conditions.
comprised of a team of industry professionals and leaders with deep insight and relationships in healthcare, software systems, mergers
and acquisitions and related fields. Digital Health was formed as a special purpose acquisition company that raised $115 million in an
initial public offering in November 2021, intending to utilize the proceeds for acquiring scalable businesses in healthcare.
contains, and certain oral statements made by representatives of Digital Health, VSee and iDoc and their respective affiliates, from
time to time may contain, "forward-looking statements" within the meaning of the "safe harbor" provisions of
the Private Securities Litigation Reform Act of 1995. Digital Health's, VSee's and iDoc's actual results may differ
from their expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions
of future events. Words such as "expect," "estimate," "project," "budget," "forecast,"
"anticipate," "intend," "plan," "may," "will," "could," "should,"
"believes," "predicts," "potential," "might" and "continues," and similar
expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, Digital
Health's, VSee's and iDoc's expectations with respect to future performance and anticipated financial impacts of the
Transactions contemplated by the Amended BCA, the satisfaction of the closing conditions to the Transactions and the timing of the completion
of the Transactions. These forward-looking statements involve significant risks and uncertainties that could cause actual results to
differ materially from expected results. Most of these factors are outside of the control of Digital Health or VSee and iDoc and are
difficult to predict. Factors that may cause such differences include but are not limited to: (i) the inability of the parties to
successfully or timely consummate the Transactions, including the risk that any required regulatory approvals are not obtained, are delayed
or are subject to unanticipated conditions that could adversely affect the post-Transactions company (the "Company") or the
expected benefits of the Transactions, if not obtained; (ii) the failure to realize the anticipated benefits of the Transactions;
(iii) matters discovered by the parties as they complete their respective due diligence investigation of the other parties; (iv) the
ability of Digital Health prior to the Transactions, and the Company following the Transactions, to maintain the listing of the Company's
shares on Nasdaq; (v) costs related to the Transactions; (vi) the lack of a third-party fairness opinion in determining whether
or not to pursue the proposed Transactions; (vii) the failure to satisfy the conditions to the consummation of the Transactions,
including the approval of the Amended BCA by the stockholders of Digital Health and the satisfaction of the minimum cash requirements
of the Amended BCA following any redemptions by Digital's public stockholders; (viii) the risk that the Transactions may not
be completed by the stated deadline and the potential failure to obtain an extension of the stated deadline; (ix) the outcome of
any legal proceedings that may be instituted against Digital Health, VSee or iDoc related to the Transactions; (x) the attraction
and retention of qualified directors, officers, employees and key personnel of Digital and VSee and iDoc prior to the Transactions, and
the Company following the Transactions; (xi) the ability of the Company to compete effectively in a highly competitive market; (xii) the
ability to protect and enhance VSee and iDoc's corporate reputation and brand; (xiii) the impact from future regulatory, judicial,
and legislative changes in VSee and iDoc's or the Company's industry; (xiv) the uncertain effects of the COVID-19 pandemic
and geopolitical developments; (xv) competition from larger technology companies that have greater resources, technology, relationships
and/or expertise; (xvi) future financial performance of the Company following the Transactions, including the ability of future
revenues to meet projected annual bookings; (xvii) the ability of the Company to forecast and maintain an adequate rate of revenue
growth and appropriately plan its expenses; (xviii) the ability of the Company to generate sufficient revenue from each of its revenue
streams; (xix) the ability of the Company's patents and patent applications to protect the Company's core technologies
from competitors; (xx) the Company's ability to manage a complex set of marketing relationships and realize projected revenues
from subscriptions, advertisements; (xxi) product sales and/or services; (xxii) the Company's ability to execute its
business plans and strategy, including potential expansion into new geographic regions; and (xxiii) other risks and uncertainties
described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with
the SEC by Digital Health. The foregoing list of factors is not exclusive. Should one or more of these risks or uncertainties materialize,
or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking
statements. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made.
Digital Health, VSee and iDoc undertake no obligation to update forward-looking statements to reflect events or circumstances after the
date they were made except as required by law or applicable regulation.
For investor inquiries
about Digital Health, VSee, or iDoc please contact:
LHA Investor Relations